These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
636 related articles for article (PubMed ID: 29799356)
21. CD98 expression is decreased in papillary carcinoma of the thyroid and Hashimoto's thyroiditis. Anderson CE; Graham C; Herriot MM; Kamel HM; Salter DM Histopathology; 2009 Dec; 55(6):683-6. PubMed ID: 19922591 [TBL] [Abstract][Full Text] [Related]
22. CD57 (Leu-7) expression is helpful in diagnosis of the follicular variant of papillary thyroid carcinoma. Khan A; Baker SP; Patwardhan NA; Pullman JM Virchows Arch; 1998 May; 432(5):427-32. PubMed ID: 9645441 [TBL] [Abstract][Full Text] [Related]
24. RET/papillary thyroid cancer rearrangement in nonneoplastic thyrocytes: follicular cells of Hashimoto's thyroiditis share low-level recombination events with a subset of papillary carcinoma. Rhoden KJ; Unger K; Salvatore G; Yilmaz Y; Vovk V; Chiappetta G; Qumsiyeh MB; Rothstein JL; Fusco A; Santoro M; Zitzelsberger H; Tallini G J Clin Endocrinol Metab; 2006 Jun; 91(6):2414-23. PubMed ID: 16595592 [TBL] [Abstract][Full Text] [Related]
25. CD56, CD57, HBME1, CK19, Galectin-3 and p63 immunohistochemical stains in differentiating diagnosis of thyroid benign/malign lesions and NIFTP. Tastekin E; Keskin E; Can N; Canberk S; Mut A; Erdogan E; Asa N; Güldiken S; Sezer A; Azatcam M Pol J Pathol; 2019; 70(4):286-294. PubMed ID: 32146798 [TBL] [Abstract][Full Text] [Related]
26. Role of Ki-67 as a proliferative marker in lesions of thyroid. Pujani M; Arora B; Pujani M; Singh SK; Tejwani N Indian J Cancer; 2010; 47(3):304-7. PubMed ID: 20587907 [TBL] [Abstract][Full Text] [Related]
27. Diffuse sclerosing variant of thyroid papillary carcinoma: diagnostic challenges occur with Hashimoto's thyroiditis. Chen CC; Chen WC; Peng SL; Huang SM J Formos Med Assoc; 2013 Jun; 112(6):358-62. PubMed ID: 23787013 [TBL] [Abstract][Full Text] [Related]
28. Defining the value of CD56, CK19, Galectin 3 and HBME-1 in diagnosis of follicular cell derived lesions of thyroid with systematic review of literature. Dunđerović D; Lipkovski JM; Boričic I; Soldatović I; Božic V; Cvejić D; Tatić S Diagn Pathol; 2015 Oct; 10():196. PubMed ID: 26503236 [TBL] [Abstract][Full Text] [Related]
29. MicroRNA analysis as a potential diagnostic tool for papillary thyroid carcinoma. Chen YT; Kitabayashi N; Zhou XK; Fahey TJ; Scognamiglio T Mod Pathol; 2008 Sep; 21(9):1139-46. PubMed ID: 18587330 [TBL] [Abstract][Full Text] [Related]
30. Significance of AgNORs and ki-67 proliferative markers in differential diagnosis of thyroid lesions. Aiad HA; Bashandy MA; Abdou AG; Zahran AA Pathol Oncol Res; 2013 Apr; 19(2):167-75. PubMed ID: 23055017 [TBL] [Abstract][Full Text] [Related]
31. Comment on: synchronous occurrence of anaplastic, follicular, and papillary carcinoma with follicular adenoma in thyroid gland. Wasim NA; Hati GC; Guha D; Bhattacharya S Indian J Pathol Microbiol; 2011; 54(2):434-5. PubMed ID: 21623130 [No Abstract] [Full Text] [Related]
32. A novel tumor marker, Niban, is expressed in subsets of thyroid tumors and Hashimoto's thyroiditis. Matsumoto F; Fujii H; Abe M; Kajino K; Kobayashi T; Matsumoto T; Ikeda K; Hino O Hum Pathol; 2006 Dec; 37(12):1592-600. PubMed ID: 16949643 [TBL] [Abstract][Full Text] [Related]
33. Synchronous occurrence of anaplastic, follicular and papillary carcinomas with follicular adenoma in thyroid gland. Bhargav PR; Gayathri KB Indian J Pathol Microbiol; 2011; 54(2):414-5; author reply 415. PubMed ID: 21623114 [No Abstract] [Full Text] [Related]
34. Utility of immunohistochemical markers in diagnosis of follicular cell derived thyroid lesions. Alshenawy HA Pathol Oncol Res; 2014 Oct; 20(4):819-28. PubMed ID: 24659044 [TBL] [Abstract][Full Text] [Related]
35. Utility of galectin 3 expression in thyroid aspirates as a diagnostic marker in differentiating benign from malignant thyroid neoplasms. Aron M; Kapila K; Verma K Indian J Pathol Microbiol; 2006 Jul; 49(3):376-80. PubMed ID: 17001889 [TBL] [Abstract][Full Text] [Related]
36. CD56 Expression in Papillary Thyroid Carcinoma Is Highly Dependent on the Histologic Subtype: A Potential Diagnostic Pitfall. Cho U; Kim Y; Jeon S; Jung CK Appl Immunohistochem Mol Morphol; 2022 May-Jun 01; 30(5):389-396. PubMed ID: 35510774 [TBL] [Abstract][Full Text] [Related]
37. [Problems in the diagnosis of thyroid papillary and follicular carcinoma]. Xue WC; Hui YZ Zhonghua Bing Li Xue Za Zhi; 2007 Apr; 36(4):220-3. PubMed ID: 17706110 [No Abstract] [Full Text] [Related]
38. Diagnostic value of qualitative and quantitative variables in thyroid lesions. Rout P; Shariff S Cytopathology; 1999 Jun; 10(3):171-9. PubMed ID: 10390065 [TBL] [Abstract][Full Text] [Related]
39. Cyclin D1 in well differentiated thyroid tumour of uncertain malignant potential. Lamba Saini M; Weynand B; Rahier J; Mourad M; Hamoir M; Marbaix E Diagn Pathol; 2015 Apr; 10():32. PubMed ID: 25907675 [TBL] [Abstract][Full Text] [Related]
40. Diagnostic criteria of well differentiated thyroid tumor of uncertain malignant potential; a histomorphological and immunohistochemical appraisal. Yassin Fel-Z J Egypt Natl Canc Inst; 2015 Jun; 27(2):59-67. PubMed ID: 25800580 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]